Delhi AIIMS Among 3 Hospitals to Conduct Phase 2/3 Trials of Bharat Biotech’s Nasal Shot

Phase 2/3 clinical trials of the intranasal vaccine are likely to begin in the next two weeks as an application has been put to seek permission of the Ethics Committee.

from Top India News- News18.com https://ift.tt/3yXag0y
via IFTTT